Nitric oxide inhibits CXCL12 expression in neuroinflammation

Immunology and Cell Biology

Volumn 91, Issue 6, 2013, Pages 427-434

  Petković, Filip ^a   Blaževski, Jana ^a   Momčilović, Miljana ^a   Mostarica Stojkovic, Marija ^a   Miljković, Djordje ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

astrocyte; CXCL12; endothelial cell; experimental autoimmune encephalomyelitis; multiple sclerosis; nitric oxide

Indexed keywords

AMINOGUANIDINE; CHEMOKINE RECEPTOR CXCR4; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; IN VIVO STUDY; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD; UPREGULATION;

ANIMALS; ASTROCYTES; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIAL CELLS; HUMANS; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, INBRED STRAINS; UP-REGULATION;

AGOUTI; ANIMALIA; RATTUS;

EID: 84879837963     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.23     Document Type: Article

References (47)

1. Krishnamoorthy G, Wekerle H. EAE: an immunologist's magic eye. Eur J Immunol 2009; 39: 2031-2035.
2. El-behi M, Rostami A, Ciric B. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 2010; 5: 189-197.
3. Li M, Ransohoff RM. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 2008; 84: 116-131.
4. Karin N. The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease. J Leukoc Biol 2010; 88: 463-473.
5. Ambrosini E, Remoli ME, Giacomini E, Rosicarelli B, Serafini B, Lande R et al. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J Neuropathol Exp Neurol 2005; 64: 706-715. (Pubitemid 41179012)
6. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006; 129: 200-211. (Pubitemid 43063771)
7. Miljković D, Stanojević Z, Momcilović M, Odoardi F, Flugel A, Mostarica-Stojković M. CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats. Immunobiology 2011; 216: 979-987.
8. Momcilović M, Mostarica-Stojković M, Miljković D. CXCL12 in control of neuroinflammation. Immunol Res 2012; 52: 53-63.
9. McCandless EE, Budde M, Lees JR, Dorsey D, Lyng E, Klein RS. IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis. J Immunol 2009; 183: 613-620.
10. Calonge E, Alonso-Lobo JM, Escando'n C, Gonza'lez N, Bermejo M, Santiago B et al. c/EBPbeta is a major regulatory element driving transcriptional activation of the CXCL12 promoter. J Mol Biol 2010; 396: 463-472.
11. Peng H, Erdmann N, Whitney N, Dou H, Gorantla S, Gendelman HE et al. HIV-1- infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta. Glia 2006; 54: 619-629. (Pubitemid 44449341)
12. Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ et al. Up-regulation of stromal cellderived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 2007; 56: 1076-1086.
13. Liu KK, Dorovini-Zis K. Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration. J Neuroimmunol 2009; 215: 49-64.
14. Smith KJ, Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002; 1: 232-241. (Pubitemid 37159185)
15. Okuda Y, Sakoda S, Fujimura H, Yanagihara T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J Neuroimmunol 1997; 73: 107-116. (Pubitemid 27105276)
16. Zettl UK, Mix E, Zielasek J, Stangel M, Hartung HP, Gold R. Apoptosis of myelinreactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell Immunol 1997; 178: 1-8. (Pubitemid 27250274)
17. Mitrovic B, Ignarro LJ, Vinters HV, Akers MA, Schmid I, Uittenbogaart C et al. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 1995; 65: 531-539.
18. Cross AH, Manning PT, Stern MK, Misko TP. Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J Neuroimmunol 1997; 80: 121-130. (Pubitemid 28015331)
19. Miljković D, Momcilović M, Stanojević Z, Rasić D, Mostarica-Stojković M. It is still not for the old iron: adjuvant effects of carbonyl iron in experimental autoimmune encephalomyelitis induction. J Neurochem 2011; 118: 205-214.
20. Saura J. Microglial cells in astroglial cultures: a cautionary note. J Neuroinflammation 2007; 4: 26.
21. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119-125. (Pubitemid 23091752)
22. Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, Raine CS et al. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J Neuroimmunol 2006; 177: 27-39. (Pubitemid 44108231)
23. Dotan I, Werner L, Vigodman S, Weiss S, Brazowski E, Maharshak N et al. CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system. Inflamm Bowel Dis 2010; 16: 583-592.
24. Zhao W, Tilton RG, Corbett JA, McDaniel ML, Misko TP, Williamson JR et al. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol 1996; 64: 123-133. (Pubitemid 26096429)
25. Brenner T, Brocke S, Szafer F, Sobel RA, Parkinson JF, Perez DH et al. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol 1997; 158: 2940-2946. (Pubitemid 127470557)
26. Shin T, Kim S, Moon C, Wie M, Kim H. Aminoguanidine-induced amelioration of autoimmune encephalomyelitis is mediated by reduced expression of inducible nitric oxide synthase in the spinal cord. Immunol Invest 2000; 29: 233-241. (Pubitemid 30616490)
27. Kahl KG, Zielasek J, Uttenthal LO, Rodrigo J, Toyka KV, Schmidt HH. Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J Neurosci Res 2003; 15: 198-205. (Pubitemid 36835420)
28. Gaundar SS, Bradstock KF, Bendall LJ. p38MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells. Cell Cycle 2009; 8: 2975-2983.
29. Garci'a-Moruja C, Alonso-Lobo JM, Rueda P, Torres C, Gonza'lez N, Bermejo M et al. Functional characterization of SDF-1 proximal promoter. J Mol Biol 2005; 22: 43-62. (Pubitemid 40461839)
30. Madge LA, May MJ. Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression. J Biol Chem 2010; 285: 38069-38077.
31. Saha RN, Jana M, Pahan K. MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. J Immunol 2007; 179: 7101-7109.
32. McCandless EE, Wang Q, Woerner BM, Harper JM, Klein RS. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 8053-8064. (Pubitemid 44846323)
33. Colamussi ML, Secchiero P, Gonelli A, Marchisio M, Zauli G, Capitani S. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway. J Leukoc Biol 2001; 69: 263-270. (Pubitemid 32163439)
34. Meiron M, Zohar Y, Anunu R, Wildbaum G, Karin N. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J Exp Med 2008; 205: 2643-2655.
35. Aboumrad E, Madec AM, Thivolet C. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes. Clin Exp Immunol 2007; 148: 432-439. (Pubitemid 46701033)
36. Yano T, Liu Z, Donovan J, Thomas MK, Habener JF. Stromal cell derived factor-1 (SDF- 1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt. Diabetes 2007; 56: 2946-2957. (Pubitemid 350223629)
37. Patel JR, McCandless EE, Dorsey D, Klein RS. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci USA 2010; 107: 11062-11067.
38. Carbajal KS, Schaumburg C, Strieter R, Kane J, Lane TE. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci USA 2010; 107: 11068-11073.
39. Aboul-Enein F, Weiser P, Hoftberger R, Lassmann H, Bradl M. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol 2006; 111: 539-547. (Pubitemid 43778958)
40. Farias AS, de la Hoz C, Castro FR, Oliveira EC, Ribeiro dos Reis JR, Silva JS et al. Nitric oxide and TNFalpha effects in experimental autoimmune encephalomyelitis demyelination. Neuroimmunomodulation 2007; 14: 32-38. (Pubitemid 47340633)
41. Ahn M, Kang J, Lee Y, Riu K, Kim Y, Jee Y et al. Pertussis toxin-induced hyperacute autoimmune encephalomyelitis in Lewis rats is correlated with increased expression of inducible nitric oxide synthase and tumor necrosis factor alpha. Neurosci Lett 2001; 308: 41-44. (Pubitemid 32607676)
42. Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates TE et al. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 2002; 70: 580-587. (Pubitemid 35253528)
43. Maeda H, Okamoto T, Akaike T. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol Chem 1998; 379: 193-200. (Pubitemid 28075979)
44. Redford EJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997; 120: 2149-2157. (Pubitemid 28014591)
45. Shrager PA, Custer W, Kazarinova K, Rasband MN, Mattson D. Nerve conduction block by nitric oxide that is mediated by the axonal environment. J Neurophysiol 1998; 79: 529-536. (Pubitemid 28095875)
46. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980; 85: 890-902. (Pubitemid 10007455)
47. Ge S, Pachter JS. Isolation and culture of microvascular endothelial cells from murine spinal cord. J Neuroimmunol 2006; 177: 209-214. (Pubitemid 44108240)